Replicor

Replicor is a clinical-stage company developing novel NUCLEIC ACID-BASED POLYMERS (NAPs): oligonucleotides whose antiviral activity is strictly dependent on the polymer chemistry of oligonucleotides which can be preserved independently of the sequence of nucleotides present. NAPs have a very important safety advantage over all other existing oligonucleotide-based drugs such as aptamers, antisense oligonucleotides and siRNA: because NAP’s activity is not sequence dependent, NAPs can be engineered with sequences which retain antiviral activity but which do not have pro-inflammatory activity or off target effects common with other oligonucleotide-based drugs, rendering them safe and well tolerated.
Company Growth (employees)
Type
Private
HQ
Montreal, CA
Size (employees)
7 (est)
Replicor is headquartered in Montreal, CA

Replicor Office Locations

Replicor has an office in Montreal
Montreal, CA (HQ)
6100 Royalmount Ave

Replicor Data and Metrics

Summary Metrics

Investors

Replicor Online and Social Media Presence

Replicor Company Life and Culture

You may also be interested in